Skip to content

Assessment of function of Gastrocnemius and Soleus during walking in able bodied adults and selective electrical stimulation of the 2 muscles.

Assessment of function of Gastrocnemius and Soleus during walking in able bodied adults and selective electrical stimulation of the 2 muscles. - Triceps Surae function in normal gait

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29753
Enrollment
10
Registered
2006-05-30
Start date
2006-06-01
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal Subjects Able Bodied subjects Normal subjects

Interventions

None listed

Sponsors

Revalidatiecentrum Het Roessingh
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Able bodie adults, age between 18 and 65years, without any musculoskeletal abnormalities and normal walking function.

Exclusion criteria

Exclusion criteria: Subjects with gait abnormalities or musculoskeletal abnormalities, younger than 18 or older than 65 years.

Design outcomes

Primary

MeasureTime frame
Kinetic and kinematic parameters such as joint rotations, moments and powers along with EMG will be primary parameters. The data will be analysed using the clinical manager for kinetic and kinematic outcomes. EMG will be analysed to differentiate phasic activity patterns of the muscles in question The cross correlation analysis will also be carried out to see if there is any evidence of overlap of EMG between the 2 muscles by comparing EMG measured with surface and fine wire electrodes. With electrical stimulation experiments same set of electrodes will be used and the EMG will be analysed in similar fashion (cross correlation studies) to see isolation of response to stimulation.

Secondary

MeasureTime frame
There are no secondary outcome parameters.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)